Evidence map›Paper›PMID 26004903›Full record

ArticleThe Journal of nutritional biochemistry2015

High intrinsic aerobic capacity and pomegranate juice are protective against macrophage atherogenecity: studies in high- vs. low-capacity runner (HCR vs. LCR) rats.

Mira Rosenblat, Nina Volkova, Zaid Abassi, Steven L Britton, Lauren G Koch, Michael Aviram

Abstract read
In one paragraph

Article in The Journal of nutritional biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Vasculoprotective Effects of Pomegranate (Frontiers in pharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Mira RosenblatThe Lipid Research Laboratory, Rambam Health Care Campus, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
Nina VolkovaThe Lipid Research Laboratory, Rambam Health Care Campus, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel.
Zaid AbassiDepartment of Physiology and Biophysics, Technion Rappaport Faculty of Medicine, Haifa, Israel.
Steven L BrittonDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI 48109-2200, USA.
Lauren G KochDepartment of Anesthesiology, University of Michigan, Ann Arbor, MI 48109-2200, USA.
Michael AviramThe Lipid Research Laboratory, Rambam Health Care Campus, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel. Electronic address: aviram@tx.technion.ac.il.
Technion – Israel Institute of Technology · ILUniversity of Michigan–Ann Arbor · USRambam Health Care Campus · IL

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Biology of Aerobic Capacity and Insulin ResistanceR01DK077200 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BURANT, CHARLES F · 2008 to 2012
$1.5M
Genotype-Phenotype relationships underlying aerobic capacity and metabolic healthR01DK099034 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRITTON, STEVEN LOYAL, BURANT, CHARLES F · 2014 to 2016
$1.4M
Inflammation resolving mechanism dysregulation in postoperative cognitive declineR01GM104194 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MAZE, MERVYN · 2013 to 2016
$1.2M
Resource for Rat Genetic Models of Aerobic CapacityR24OD010950 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BRITTON, STEVEN LOYAL · 2012 to 2013
$1.0M
NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK077200NIDDK NIH HHS R01DK077200NIDDK NIH HHS R01 DK099034NIDDK NIH HHS R01DK099034NIGMS NIH HHS R01 GM104194NIGMS NIH HHS R01GM104194NIH HHS R24 OD010950NIH HHS R24OD010950
6 · The paper itself

Abstract

We studied the rat model system of high- vs. low-capacity runner (HCR vs. LCR) rats to question the atherogenic properties (oxidative stress, triglycerides and cholesterol metabolism) in the rat macrophages, serum, liver and heart. Half of the LCR or HCR rats consumed pomegranate juice (PJ; 15 μmol of gallic acid equivalents/rat/day) for 3 weeks and were compared to placebo-treated rats. At the end of the study blood samples, peritoneal macrophages (RPM), livers, and hearts were harvested from the rats. RPM harvested from HCR vs. LCR demonstrated reduced cellular oxidation (21%), increased paraoxonase 2 activity (28%) and decreased triglycerides mass (44%). Macrophage uptake rates of fluorescein-isothiocyanate-labeled low-density lipoprotein (LDL) or oxidized LDL were significantly lower, by 37% or by 18%, respectively, in HCR vs. LCR RPM. PJ consumption significantly decreased all the above atherogenic parameters with more substantial beneficial effects observed in the LCR vs. the HCR rats (~80% vs. ~40% improvement, respectively). Similar hypo-triglyceridemic pattern was noted in serum from HCR vs. LCR. In contrast to the above results, liver oxidation and triglycerides mass were both minimally increased in HCR vs. LCR rats by 31% and 28%, respectively. In the heart, lipid content was very low, and interestingly, an absence of any significant oxidative stress, along with modest triglyceride accumulation, was observed. We conclude that HCR vs. LCR rats demonstrate reduced atherogenicity, mostly in their macrophages. PJ exerts a further improvement, mostly in macrophages from LCR rats.

Indexed as

BeveragesLythraceaeRunningAnimalsAntioxidantsAtherosclerosisFruitLipidsLipoproteins, LDLLiverMacrophagesMacrophages, PeritonealMaleMyocardiumOxidative StressPhysical EnduranceAntioxidantsLipidsLipoproteins, LDLoxidized low density lipoproteinTriglyceridesHCR ratsHeartLCR ratsLiverOxidative stressPomegranate juiceRat peritoneal macrophages

Identifiers

PMID26004903
PMCPMC4578978
OpenAlexW1686099574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.